Fierce Biotech

Embecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulin

Published

3 weeks ago

on

Embecta has agreed to pay 100 million pounds sterling upfront for the company, or about $134.3 million, plus another 50 million pounds in sales milestones.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version